Gainers
- AERWINS Technologies Inc. AWIN shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not limited to possible sale/other disposition of assets.
- RVL Pharmaceuticals plc RVLP shares rose 24.5% to $0.1078 in pre-market trading after gaining over 10% on Friday.
- Better Choice Company Inc. BTTR shares gained 21.4% to $0.1505 in pre-market trading after gaining 5% on Friday.
- Bionomics Limited BNOX shares rose 21.1% to $3.27 in pre-market trading after falling 20% on Friday.
- Athena Consumer Acquisition Corp. ACAQ shares surged 20.4% to $8.98 in pre-market trading after falling 20% on Friday.
- EMCORE Corporation EMKR rose 19.7% to $0.5691 in pre-market trading after falling 5% on Friday.
- Syndax Pharmaceuticals, Inc.. SNDX gained 13.6% to $16.50 in pre-market trading. Syndax will share topline results from the pivotal AUGMENT-101 trial in patients with relapsed/refractory KMT2Ar acute leukemia on Oct. 2, 2023.
- Bitfarms Ltd. BITF shares climbed 13.1% to $1.21 in pre-market trading.
- Femasys Inc. FEMY rose 11.1% to $3.31 in pre-market trading. Femasys shares jumped 46% on Friday after HC Wainwright maintained a Buy rating on the stock and raised its price target from $5 to $13.
- Oragenics, Inc. OGEN shares jumped 10.4% to $3.28 in pre-market trading after the company entered into agreement with Lantern Bioworks for replacement-therapy assets.
Losers
- SmileDirectClub, Inc. SDC fell 64.1% to $0.1489 in pre-market trading. SmileDirectClub filed for bankruptcy just a few years after its remarkable $1.35 billion IPO.
- Intelligent Bio Solutions Inc. INBS fell 23.8% to $0.80 in pre-market trading after declining 7% on Friday.
- Context Therapeutics Inc. CNTX shares fell 15.8% to $1.27 in pre-market trading after jumping around 19% on Friday.
- Nexalin Technology, Inc. NXL fell 14.7% to $0.3752 in pre-market trading. On Sept. 21, 2023, Marilyn Elson submitted her resignation as CFO Of Nexalin Technology.
- ReShape Lifesciences Inc. RSLS shares fell 14.2% to $0.2901 in pre-market trading after declining 23% on Friday. ReShape Lifesciences reported pricing of $3.0 million public offering.
- Brooge Energy Limited BROG fell 9.8% to $5.02 in pre-market trading. Brooge Energy said revenue jumped 122% year-over-year to $62.9 million for the first six months ending June 30, 2023.
- Danaher Corporation DHR shares fell 9.6% to $224.32 in pre-market trading. Danaher said it completed separation of Veralto Corporation.
- Siyata Mobile Inc. SYTA fell 9.6% to $2.55 in pre-market trading.
- Grom Social Enterprises Inc GROM fell 8% to $1.26 in pre-market trading. Grom Social recently priced a $3 million offering.
- Bolt Biotherapeutics Inc BOLT fell 7.7% to $0.96 in pre-market. The FDA recently granted Orphan Drug Designation for Bolt Biotherapeutics' BDC-1001 for gastric cancer, including gastroesophageal junction cancer.
Now Read This: Nio, Li Auto And 3 Stocks To Watch Heading Into Monday
BITFBitfarms Ltd
$1.618.05%
BNOX
$0.400258.1%
BOLTBolt Biotherapeutics Inc
$0.58008.39%
BROGBrooge Energy Ltd
$1.601.91%
BTTRBetter Choice Co Inc
$2.391.70%
CNTXContext Therapeutics Inc
$1.3023.8%
DHRDanaher Corp
$229.810.11%
EMKREMCORE Corp
$3.010.33%
FEMYFemasys Inc
$1.07-2.73%
GROMGrom Social Enterprises Inc
$0.02506150.0%
INBSIntelligent Bio Solutions Inc
$1.421.32%
NXLNexalin Technology Inc
$3.1213.2%
OGENOragenics Inc
$0.3599-2.55%
RSLSReshape Lifesciences Inc
$4.24-4.93%
SNDXSyndax Pharmaceuticals Inc
$14.177.19%
SYTASiyata Mobile Inc
$5.86-3.62%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in